Dicerna Pharma (DRNA) Reports In-Line Q4 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. ANET
6. DUOL
7. SWKS
8. XYZ
9. CVS
10. FISV

Go back to Dicerna Pharma (DRNA) Reports In-Line Q4 EPS

Dicerna Pharmaceuticals (DRNA) PT Lifted to $40 at Leerink Partners Post Q4

March 13, 2015 7:43 AM EDT

Leerink Partners analyst Michael Schmidt reiterated an Outperform rating and boosted his price target on Dicerna Pharmaceuticals (NASDAQ: DRNA) to $40.00 (from $25.00) following 4Q14 financial results and a pipeline update.

Schmidt commented, "DRNA reported 4Q14 financial results and provided a pipeline update. Two... More

Dicerna Pharma (DRNA) Fils 10.7M Common Shelf for Shareholders; $50M Mixed Shelf

March 12, 2015 4:48 PM EDT

Dicerna Pharma (NASDAQ: DRNA) filed to sell up to 10,687,733 shares of Common Stock on behalf of Selling Stockholders, 10 million shares of common stock, and $50 million of mixed securities.

... More